A Phase III Clinical Trial to Study the Safety and Immunogenicity of Pneumovax™ 23 (V110) in Participants From the Russian Population (V110-018)
Clinical trial NCT01734239 · COMPLETED
Trial details
- NCT number
- NCT01734239
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-06-03
- Primary completion
- 2013-10-22
- Enrollment
- 102
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.